TDP1 and cancer: Moreover, the potential development of Tdp1-poisons, compounds that selectively increase the lifetime of Tdp1-DNA adducts similar to Tdp1 catalytic mutants such as the SCAN1 mutant, would be a welcome addition for combinational treatment options for anti-cancer therapy.